Ceftaroline Fosamil 7-Position Side Chain CAS 75028-24-9 Maʻemaʻe: ≥99.0% (HPLC)

ʻO ka wehewehe pōkole:

(Z)-2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-(ethoxyimino)acetic acid;ʻO Ceftaroline Fosamil 7-Position ʻaoʻao kaulahao

CAS: 75028-24-9

Maʻemaʻe: ≥99.0% (HPLC)

ʻAno: Keʻokeʻo a me ka Māmā Melemele Crystalline Powder

ʻO ka waena o Ceftaroline Fosamil (TAK-599), kahi derivative Cephalosporin

ʻO ke kūlana kiʻekiʻe, ka hana kālepa

E-Mail: alvin@ruifuchem.com

E hoʻouna i ka leka uila iā mākou

Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

Hoʻolako Mea Hana me ka Maʻemaʻe kiʻekiʻe a me ka maikaʻi paʻa
Inoa Kemika: (Z)-2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-(ethoxyimino)acetic acid
CAS: 75028-24-9

Na Waiwai Kemika:

Inoa Kimia	(Z)-2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-(ethoxyimino)acetic acid
Nā huaʻōlelo like	ʻO Ceftaroline Fosamil 7-Position Side Chain;ATDE
Helu CAS	75028-24-9
Helu CAT	RF-PI559
Kūlana Kūʻai	Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā tona
ʻĀpana Molekala	C6H8N4O3S
Kaumaha Molecular	216.22
Brand	ʻO Ruifu Chemical

Nā kikoʻī:

'ikamu	Nā kikoʻī
Ka nana aku	Keʻokeʻo a i ka ʻulaʻula melemele Crystalline pauda
Maʻemaʻe / Kaʻina Hanana	≥99.0% (HPLC)
Māmā (KF)	≤0.50%
Hoʻokahi haumia	≤0.50%
Huina paumaele	≤1.0%
Kūlana hoʻāʻo	ʻOihana Kūlana
Hoʻohana	ʻO ka waena o Ceftaroline Fosamil (TAK-599), kahi derivative Cephalosporin

Pūʻolo a me ka waiho ʻana:

Pūʻolo: ʻO ka ʻōmole, ʻeke ʻeke alumini, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai.

Pono:

FAQ:

Noi:

(Z)-2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-(ethoxyimino)acetic acid (CAS: 75028-24-9) he mea koʻikoʻi ia no ka hoʻomākaukau ʻana i ka Ceftaroline Fosamil. (TAK-599).ʻO Ceftaroline fosamil kahi cephalosporin me ka hana e kūʻē i nā pathogens Gram-positive, me ka methicillin-resistant Staphylococcus aureus (MRSA).ʻO Ceftaroline Fosamil kahi lāʻau lapaʻau o Ceftaroline.Ke kūkulu ʻia nei e Forest Laboratories, ma lalo o kahi laikini mai Takeda.Ua loaʻa iā ia ka ʻae ʻia mai ka US Food and Drug Administration (FDA) no ka mālama ʻana i ka maʻi maʻi bacterial i loaʻa i ke kaiāulu a me nā maʻi ʻili bacteria ma ka lā 29 ʻOkakopa 2010.